Skip to main content

Table 2 Results of percutaneous transjejunal biliary intervention (PTJBI) for benign biliary strictures and stones

From: Two decades of percutaneous transjejunal biliary intervention for benign biliary disease: a review of the intervention nature and complications

Benign strictures and stones

 

No. of interventions per patient

No. of interventions per year

Interval between biliary-enteric anastomosis and initial PTJBI (weeks)

Interval between interventions (weeks)

 

n (%)

Interventions

Mean

Range

Mean

Range

Mean

Range

Mean

Range

Diagnosis

Post-cholecystectomy injury

39 (62%)

272

7

1–40

1.45

0.29–3.33

202.4

2.7–1,279.6

49.3

0.3–314.1

Recurrent pyogenic cholangitis

6 (9.5%)

90

15

3–40

2.34

1.60–3.25

69.5

3.7–253.1

19.5

14.0–32.9

Primary sclerosing cholangitis

6 (9.5%)

39

6

2–13

0.90

0.40–1.30

40.3

2.3–211.3

79.4

36.0–79.4

Caroli’s disease

7 (11%)

73

10

1–32

1.40

0.30–3.56

130.7

3.9–498.0

87.9

14.3–223.4

Other

5 (8%)

20

4

1–7

2.17

1.00–3.50

44.9

4.9–149.1

20.2

2.9–36.8

Total

63

494

8

 

1.7 (p = 0.016)

 

98.0 (p > 0.05)

 

51.3 (p = 0.041)

 

Bismuth classificationa

Bismuth I and II

18 (46.2%)

90

5

1–17

1.30

0.30–3.00

312.3

2.7–1279.6

57.7

11.2–228.1

Bismuth III

8 (20.5%)

47

6

1–14

1.31

0.29–2.00

212.8

6.0–770.9

69.5

0.3–314.1

Bismuth IV

13 (33.3%)

135

10

1–40

1.78

1.00–3.33

84.0

6.9–209.6

26.6

9.4–57.1

Total

39

272

7

 

1.45 (p > 0.05)

 

202.4 (p > 0.05)

 

49.3 (p > 0.05)

 

Dominant underlying pathology

Stone group

15 (23.8%)

118

8

1–32

1.23

0.30–3.56

78.1

2.3–498.0

43.9

0.3–314.1

Stricture group

48 (76.2%)

376

8

1–40

1.69 (p = 0.045)

0.29–3.50 (p = 0.031)

178.3

2.7–1,279.6

72.8 (p = 0.016)

2.9–223.4

  1. a Post-cholecystectomy injury patients only